Who
Shelly Wong
SVP, Finance and CAO
Company insider
Files Form 4 as: SVP, Finance and CAO, ALX Oncology Holdings.
In numbers
- Trades disclosed
- 41
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $170K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 May 2020
- Last trade
- 17 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 18 Aug 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $1,106573 at $1.93 | filing |
| 17 Aug 2026filed 18 Aug 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $1,106573 at $1.93 | filing |
| 1 Jul 2026filed 6 Jul 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $2,8641,404 at $2.04 | filing |
| 1 Jul 2026filed 6 Jul 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $2,8641,404 at $2.04 | filing |
| 19 Mar 2026filed 23 Mar 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $1,960903 at $2.17 | filing |
| 19 Mar 2026filed 23 Mar 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $1,960903 at $2.17 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $1,283565 at $2.27 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $1,283565 at $2.27 | filing |
| 26 Jan 2026filed 28 Jan 2026 | ALXO ALX Oncology Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —192,000 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | ALXO ALX Oncology Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —192,000 at $0.00 | filing |
| 6 Jan 2026filed 7 Jan 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $4,3573,925 at $1.11 | filing |
| 6 Jan 2026filed 7 Jan 2026 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $4,3573,925 at $1.11 | filing |
| 14 Oct 2025filed 16 Oct 2025 | ALXO ALX Oncology Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $391611 at $0.64 | filing |
| 7 Jul 2025filed 8 Jul 2025 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $9052,011 at $0.45 | filing |
| 30 Jun 2025filed 1 Jul 2025 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $6591,532 at $0.43 | filing |
| 11 Apr 2025filed 15 Apr 2025 | ALXO ALX Oncology Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 14 Mar 2025filed 18 Mar 2025 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ALXO ALX Oncology HoldingsBiotechnology | SEC FORM 4 Sold | $633550 at $1.15 | filing |
| 21 Jan 2025filed 23 Jan 2025 | ALXO ALX Oncology Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.